PEARL Act
Rep. Burchett Introduces PEARL Act to Protect Pharmacists Who Refuse to Provide Abortion Drugs
The PEARL Act is currently in the early stages of the legislative process. It was recently sent to the House Committee on Energy and Commerce for review. The bill is actively moving forward as it waits for the committee to discuss it.
Legislative Progress
This bill deals with a very controversial topic and is unlikely to get the support needed to pass through a divided Congress.
Key Points
Impact Analysis
Personal Impact
Life & Work
People seeking medication abortions could face delays or outright inability to fill prescriptions if their local pharmacist refuses to dispense mifepristone or misoprostol on religious grounds. This could be especially challenging in rural areas or places with few pharmacies, where patients may have limited alternatives. The bill does not require pharmacists to refer patients elsewhere, potentially leaving some people without a clear path to obtaining legally prescribed medication.
“a pharmacist (including a pharmacist employed by a private business or government agency) shall not be required to dispense or sell, nor be subject to any punishment (including revocation of a license to practice pharmacy or the withdrawal of Federal funding) for choosing not to dispense or sell, the drugs mifepristone and misoprostol for abortion services”
Programs
Disabilities
Milestones
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
PEARL Act
Data Sources
Sponsor
Analysis generated by AI. Always verify with official sources.